BNP and NTproBNP predict echocardiographic severity of diastolic dysfunction

J Grewal, R McKelvie, E Lonn, P Tait… - … of heart failure, 2008 - Wiley Online Library
… BNP and NT-proBNP are … impairment of myocardial microcirculation, reduction of coronary
flow reserve, hyperglycaemia, poor metabolic control, endothelial dysfunction and myocardial

BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine

Z Cao, Y Jia, B Zhu - International journal of molecular sciences, 2019 - mdpi.com
proBNP (NT-proBNP) are widely used as diagnostic biomarkers for heart failure (HF) and
cardiac dysfunction … They are also used as postmortem biomarkers reflecting cardiac function …

NT-ProBNP: the mechanism behind the marker

C Hall - Journal of cardiac failure, 2005 - Elsevier
… The recently demonstrated production of BNP by stimulated cardiac … main cardiac
production site, but as heart failure develops, there is a profound activation of ventricular NT-proBNP

Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NTPROBNP): a new marker of cardiac impairment

PJ Hunt, AM Richards, MG Nicholls… - Clinical …, 1997 - Wiley Online Library
… the amino terminal portion of proBNP, proBNP(1–76) … proBNP (proBNP(1–76) or NTproBNP)
remain unclear, our recent detection of NT-proBNPlike material in extracts of human cardiac

Essential biochemistry and physiology of (NTpro) BNP

C Hall - European journal of heart failure, 2004 - Wiley Online Library
ProBNP is split into NT-proBNP and BNP by the protease … cardiac (Nt-pro)BNP production
is cardiac wall stress. When chronic heart failure develops there is a relative shift in cardiac (Nt-…

Use of NTproBNP in routine testing and comparison to BNP

R Pfister, M Scholz, K Wielckens… - … of heart failure, 2004 - Wiley Online Library
… severe systolic LV-dysfunction by echocardiography in a … were first, to evaluate NT-proBNP
as a marker of LV-dysfunction in a large, … of NT-proBNP to other cardiac diseases. Therefore, …

Serum NTpro BNP in the early detection of doxorubicin‐induced cardiac dysfunction

A Kittiwarawut, Y Vorasettakarnkij… - Asia‐Pacific Journal …, 2013 - Wiley Online Library
Cardiac dysfunction is a major limitation of anthracycline treatment in cancer patients. There
… N-terminal pro-brain-natriuretic peptide (NT-proBNP), troponin-T and creatine kinase MB …

Relation between NTproBNP levels, iron overload, and early stage of myocardial dysfunction in β‐thalassemia major patients

C Balkan, SY Tuluce, G Basol, K Tuluce, Y Ay… - …, 2012 - Wiley Online Library
NT-proBNP levels, iron overload, and various echocardiographic indices of myocardial
dysfunction in … While there was a strong correlation between plasma NT-proBNP levels and iron …

NTproBNP in heart failure: therapy decisions and monitoring

M Richards, RW Troughton - European journal of heart failure, 2004 - Wiley Online Library
… With increasing cardiac dysfunction, synthesis and release of cardiac natriuretic peptides …
observed in heart failure. Plasma concentrations of the cardiac natriuretic peptides and their pro…

Serum N-terminal pro–brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis

G Palladini, C Campana, C Klersy, A Balduini… - Circulation, 2003 - Am Heart Assoc
NT-proBNP appeared to be more sensitive than conventional echocardiographic …
Conclusions— NT-proBNP appeared to be the most sensitive index of myocardial dysfunction and …